The In Vitro Diagnostic CRO

Similar documents
MCRA Clinical More Than Your Average CRO. Clinical Project Management. Site Management and Study Monitoring. Data Management. Auxiliary Services

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Disclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs

GxP Auditing, Remediation, and Staff Augmentation

Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm

GxP Auditing, Remediation, and Quality System Resourcing

GxP Auditing, Remediation, and Staff Augmentation

THERAPEUTIC AREAS CARDIOVASCULAR RESEARCH

Course Title ID Duration Basic Premium. Biological Evaluation of Medical Devices: A Risk-Based Approach N mins

FDA Regulation of Companion Diagnostics

AT A GLANCE. inventivhealthclinical.com

Recent Initiatives in Precision Medicine PMC Policy Committee Meeting February 20, Laura Koontz, Ph.D. Personalized Medicine Staff CDRH/OIR

Regulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC

ADB Consulting & CRO Inc.

Oversight of Laboratory Developed Tests

Department At-A-Glance

A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation

FDA s Proposed Regulatory Changes to Laboratory-Developed Tests (LDTs) By Roz Sweeney, Ph.D., Nerac Analyst

Specialty Lab Services. Deep science at scale

Confronting MedTech Start-Ups Three Biggest Challenges: Initiating Regulatory & Quality

STRATEGIC RESOURCING. inventivhealthclinical.com

FRAMEWORK OF CHARACTERISTICS OF A QUALIFIED SITE TEAM: How Does Yours Measure Up?

Draft Guidance for Industry, Clinical Laboratories, and FDA Staff. In Vitro Diagnostic Multivariate Index Assays

DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE

BIOSCIENTIA. Good outcomes are based on good values. Central lab services and biomarker analytics for clinical trials

KNOW-HOW AND ACCURACY IN CLINICAL RESEARCH

KNOW-HOW AND ACCURACY IN CLINICAL RESEARCH

Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules

Molecular Diagnostics Regulation Shifting from a Biomarker-Based Approach to an Algorithm-Based Approach

Agenda. - Introduction Howard Birndorf. - ASR Issues and the Draft ASR FAQ Guidance Patrick Balthrop

SALDA In Vitro Diagnostics in South Africa. Welcome. December 2015

How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations. The complete guide to developing or expanding your lab

Molecular Diagnosis Challenges & Solutions. Using Molecular Kits or Laboratory Developed Tests (Home Brew), Emphasis on Validation

Overview of the FDA Approval Process for TB Diagnostics

MEDICAL DEVICES STUDIES

October 25, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Current Topics in NYS Clinical Laboratory Oversight

Staffing - Medical Devices

MCW Office of Research Standard Operating Procedure

CRO partner in Rx/CDx Co-Development

March 19, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852

Device research sponsors, whether companies or investigators, are held responsible for meeting the same regulations.

3.1. Overall Principal Investigator (PI), who holds the IDE and/or is the Sponsor

Developing a Companion Diagnostics in parallel to a medicinal product Legal and Regulatory requirements in Europe and in the US

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155

Simplifying Clinical Trials

Research Job Summaries

LDT Review: The New York Experience

HELPING DELIVER LIFE-CHANGING THERAPIES HEMATOLOGY ONCOLOGY

June 15, Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB

Clinical Research Professionals Working Group l RPL Readiness Tool

Corporate Presentation. October 2017

Expanded Access and the Individual Patient IND

Explore the World of End-to-End. Integrated Lab Performance

PAREXEL ACCESS MANAGED ACCESS PROGRAMS

Incorporating FDA Regulatory Thinking into Plans for Medical Devices

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

IMARC Research, Inc. Executive Summary. Independent. Monitoring. Auditing. Research. Consulting WE LL EARN YOUR APPROVAL.

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: July 14, 2011

Clinical Research with Drugs/Biologics and Devices & Good Clinical Practices

Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA Zenaida Power Regulatory Expertise:

Clinical Trials Management for Molecular Diagnostics. April 2016

Clinical Research Service Provider Information Form

Regulatory Affairs, Compliance Assurance, Quality Systems, Remediation Strategy and Support, and Strategic Consulting Services

Curriculum Vitae. SENIOR VICE PRESIDENT JAMES P. KULLA Mobile Phone:

OMBU. Ombu Enterprises, LLC Ombu The Operational Excellence Company Ph: Fax: ENTERPRISES, LLC

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer

Complex Generics: Charting a new path

Your bridge to. better medicines

Re: Docket No. FDA-2017-D ; Draft Guidance on Recommendations for Dual 510(k) and CLIA Waiver by Application Studies

Latham & Watkins Corporate Department

An integrated model approach to improve the management of marketed products

Regulatory & Reimbursement Policy Trends Affecting Market Access for Diagnostic Devices Emphasis on Validity and Quality

Performance Profile. Medical Clinical Director. 1

Trial Services. The allround trial specialist in cardiology Leading since cardialysis.com

Advancing utility and adoption of clinical genomic diagnostics

General Comments. May 30, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

College of American Pathologists. Statement to the National Institutes of Health on the proposed Genetic Testing Registry.

QUALITY ASSURANCE. Pharma Quality Agreements: What Are They, and Why They Matter For Your Study ABSTRACT

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

Conducted Under an IND to Support a

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

FDA Regulation of Testing

Paths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005

KINGSMANN CARE GROUP

Dedicated to Molecular Diagnostics

Structure and Mandate of FDA

To document the review procedures for a submission regarding compassionate/treatment use of investigational drugs, biologics and devices.

Further excellence. Freedom of association. How can you enhance social responsibility within your supply chain? Social responsibility Audit solutions

2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)

2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)

Managing Multi-Arm Studies

Regulatory Structure, Science and Compliance in a Medical Device Manufacturer. Disclaimer Statement

2012 European Integrated Point-of-Care Diagnostic Platforms Technology Innovation Award

EXPERT ISE YOU CAN TRUST

U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical Devices

Personalised Healthcare Solutions (PHCS) Excellence for your Biomarker-driven Strategies

Helping unlock growth opportunities worldwide

FDA Inspections: FDA Inspections: An Overview Overview

Transcription:

The In Vitro Diagnostic CRO

Choose Beaufort Because of Our People, Processes and Proven Experience The value of expertise cannot be overstated, especially when it comes to streamlining complicated in vitro diagnostic research projects. At Beaufort, we bring to every client the knowledge gained from a leadership team that averages more than 30 years of industry experience. This has earned us a reputation for being responsive and efficient and developing customized solutions that help establish and maintain excellence for our clients. Beaufort maximizes operational and regulatory success by providing more specialized IVD expertise than any other CRO. We offer client-focused solutions across a wide array of IVD assays including personalized medicine, molecular diagnostics, biomarker verification and validation, and conversion of laboratory developed tests to globally regulated diagnostic assays. Our experience with hundreds of successful 510(k) clearances and numerous PMA approvals, clinical trials, and successful consulting engagements ensures that Beaufort clients receive: Improved IVD research performance through our deep understanding of the specific requirements and nuances of diagnostic studies Reduced time to market as a result of our effective regulatory submission and negotiation strategies Well-run clinical trials through efficient clinical project management Maximized project viability utilizing our successful protocol and study plan designs High-performing investigators and sites because of our rigorous evaluation process and proprietary site database Better control and quality through our established data collection and management plans Whether you need Clinical and Regulatory Services, Data Management and Biostatistics, Quality Solutions or Staffing Solutions, Beaufort has earned a reputation for excellence as the diagnostic CRO with a commitment to best-inclass solutions. Specialties Molecular diagnostics Companion diagnostics Genomic and proteomic testing Home use tests Laboratory developed tests POC / CLIA waived tests IVD Therapeutic Expertise Allergens Cardiology Clinical chemistry Diabetes Genetic testing Hematology Immunology Infectious diseases Microbiology Oncology Respiratory diseases Women s health and prenatal testing BeaufortCRO.com info@beaufortcro.com

Clinical Trial Services Beaufort specializes in comprehensive IVD study management and monitoring. We fully manage and provide strategic assistance for every stage of your IVD product development. Or we will provide one or more stand-alone services to complement your internal resources. Services include: Clinical trial strategy / Trial design Clinical site selection and initiation Clinical trial management and coordination Selection, training and management of clinical research associates (CRAs) Safety management Data management and biostatistics Clinical report preparation FDA BIMO / Clinical site / Sponsor audits and training SAS programming services CLIA waiver studies Regulatory Affairs A sound regulatory strategy sets the foundation for successful health care innovation. This is particularly relevant when developing medical devices including highly sophisticated IVD products as well as laboratory developed tests that face increased oversight and evolving regulations. With hundreds of submissions in our portfolio, Beaufort supports successful scientific innovation for IVD companies in the U.S. and globally. Services include: Regulatory strategy Device classification Intended use statement Predicate device identification Clinical protocol design Regulatory agency liaison Decision tree analysis guidance Regulatory consulting and training Regulatory submissions - Pre-submissions - Investigational device exemption (IDE) - Premarket notification (510(k)) - De novo (evaluation of automatic Class III designation) - Premarket approval application (PMA) - Request for designation (RFD) - CE mark - CLIA waiver Post-market support Statistical support (sample size and SAP development)

Companion Diagnostics As the delivery of individualized medicine becomes more prominent, so does the need for IVD companion diagnostic devices. Our broad therapeutic knowledge, worldwide reach and experience in developing specialized diagnostics make us a tested and proven choice for companion diagnostics. We help companies: Beaufort s ability to grasp and articulate the clinical value in the field of in vitro diagnostics enabled our company to strategically align our FDA trials and submissions to meet the ever-increasing standards of the FDA. Manager, Clinical and Scientific Affairs, Leading Global Diagnostic Company Develop IVD companion diagnostic devices to identify patients most likely to benefit from a therapeutic product Identify patients most likely to be at increased risk for serious adverse events as a result of treatment from a therapeutic product Develop complimentary diagnostics that monitor patients response to treatment with a therapeutic product Develop follow-on or me too companion diagnostics Our services include: Biomarker assay verification and validation Clinical trial assay development CDx device protocols IRB submission and approval Quality system regulation (21 CFR 820) compliance Preapproval inspection readiness Regulatory expertise - Pre-submission - Investigational device exemption (IDE) - Premarket notification (510(k)) - Premarket approval application (PMA) - CE mark BeaufortCRO.com info@beaufortcro.com

Staffing Solutions Beaufort Staffing Solutions is the global staffing expert for the in vitro diagnostic industry. Set apart by unparalleled client support and our unique recruitment model, we deliver staffing solutions that drive client performance. Our strength is a vast network of highly experienced IVD professionals and how we put that experience to work for clients. Because our network spans more than 40 countries, we can rapidly deploy a skilled and dedicated team to meet your needs wherever you are and ensure a fluency of the language and the culture. Beaufort offers solutions across a full range of functional roles, including: Project Management Clinical Operations Quality Assurance Regulatory Affairs Data Management Biostatistics Medical Monitoring Medical Writing Beaufort Staffing Solutions gives you flexibility. Whether you re staffing a single position or an entire team, seeking interim support or a permanent staff member, we deliver the professionals you need to get the job done. Beaufort s clinical trial monitors represent the Gold Standard! Senior Associate Director, Top 15 Global Healthcare Company Quality Solutions Beaufort s global operations provide unparalleled expertise in quality assurance services for IVD development. We go beyond establishing compliance to ensure conformance, control and continuous improvement. With a full suite of services including GxP auditing, Corrective and Preventative Action (CAPA) management and compliance consulting, we help you design, optimize and review processes to ensure your product development adheres to regulatory guidelines and expectations. Our services include: Quality system assessment and support including gap analysis, risk management, and system design, training and implementation Supplier management including audits, management programs and strategic sourcing Inspection readiness and support including mock inspections, interviews, and inspection management CAPA system design and management including system design and implementation, root cause analysis, tracking, prevention management and reporting Compliance including quality system audit execution (FDA QSR, ISO 13485, etc.) and FDA 483 responses

About Beaufort Beaufort is a contract research organization that provides in vitro diagnostic, medical device and biopharmaceutical clinical and regulatory services, and a full range of quality solutions and staffing solutions. For more than a decade, companies worldwide have trusted Beaufort for its clientoriented approach to research. With operations spanning the globe, Beaufort has a proven track record working closely with clients and regulatory agencies internationally to bring our clients products to market Learn more about Beaufort online at beaufortcro.com. You can also contact us at info@beaufortcro.com or 757-383-6000 to find out how we can put our experience to work for you. 999 Waterside Drive Suite 1010 Norfolk, VA 23510 Phone: (757) 383-6000 BeaufortCRO.com info@beaufortcro.com